Mundipharma Pharmaceuticals B.V.

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

Oxycodone and naloxone · Pain
Oxycodone is a mu-opioid receptor agonist, while naloxone is a mu-opioid receptor antagonist.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Mundipharma Pharmaceuticals B.V. portfolio CI brief
Mundipharma Pharmaceuticals B.V. pipeline updates RSS